These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 29285735

  • 21. [Immunogenicity of biosimilars].
    van Aerts LA, Franken AA, Leufkens HG.
    Ned Tijdschr Geneeskd; 2016; 160():D888. PubMed ID: 28000573
    [Abstract] [Full Text] [Related]

  • 22. Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody.
    Xiang Y, Parng C, Olson K, Seletskaia E, Gorovits B, Jani D, Caiazzo T, Joyce A, Donley J.
    AAPS J; 2019 Mar 29; 21(3):46. PubMed ID: 30927117
    [Abstract] [Full Text] [Related]

  • 23. The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects.
    Declerck P, Danesi R, Petersel D, Jacobs I.
    Drugs; 2017 Apr 29; 77(6):671-677. PubMed ID: 28258517
    [Abstract] [Full Text] [Related]

  • 24. Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.
    Cuello HA, Segatori VI, Alberto M, Pesce A, Alonso DF, Gabri MR.
    BioDrugs; 2016 Jun 29; 30(3):225-31. PubMed ID: 27053342
    [Abstract] [Full Text] [Related]

  • 25. The use of pharmacometrics to optimize biosimilar development.
    Dodds M, Chow V, Markus R, Pérez-Ruixo JJ, Shen D, Gibbs M.
    J Pharm Sci; 2013 Nov 29; 102(11):3908-14. PubMed ID: 24027111
    [Abstract] [Full Text] [Related]

  • 26. Biosimilars in ulcerative colitis: When and for who?
    Ilias A, Gonczi L, Kurti Z, Lakatos PL.
    Best Pract Res Clin Gastroenterol; 2018 Nov 29; 32-33():35-42. PubMed ID: 30060937
    [Abstract] [Full Text] [Related]

  • 27. An update on the animal studies conducted for biosimilar approvals - Regulatory requirement vs actual scenario.
    Pipalava P, Patel R, Mehta M, Dahiya M, Singh I, Jose V.
    Regul Toxicol Pharmacol; 2019 Oct 29; 107():104415. PubMed ID: 31254556
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review.
    Moots RJ, Curiale C, Petersel D, Rolland C, Jones H, Mysler E.
    BioDrugs; 2018 Jun 29; 32(3):193-199. PubMed ID: 29790131
    [Abstract] [Full Text] [Related]

  • 33. An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements.
    Buske C, Ogura M, Kwon HC, Yoon SW.
    Future Oncol; 2017 May 29; 13(15s):5-16. PubMed ID: 28482702
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Key considerations in the preclinical development of biosimilars.
    Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM.
    Drug Discov Today; 2015 May 29; 20 Suppl 1():3-15. PubMed ID: 25912284
    [Abstract] [Full Text] [Related]

  • 37. Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development.
    Thway TM, Wang YM, Booth BP, Maxfield K, Huang SM, Zineh I.
    AAPS J; 2019 Dec 19; 22(1):15. PubMed ID: 31858313
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin.
    Gianoncelli A, Bonini SA, Bertuzzi M, Guarienti M, Vezzoli S, Kumar R, Delbarba A, Mastinu A, Sigala S, Spano P, Pani L, Pecorelli S, Memo M.
    BioDrugs; 2015 Aug 19; 29(4):285-300. PubMed ID: 26334631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.